Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
131.5 USD | -0.20% | +0.85% | +20.47% |
05-15 | Merck to present new oncology data | CF |
05-14 | US FDA declines to approve expanded use of Dynavax's hepatitis B vaccine | RE |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+20.47% | 334B | |
+33.76% | 709B | |
+30.55% | 595B | |
-2.32% | 367B | |
+5.14% | 289B | |
+14.19% | 239B | |
+9.05% | 211B | |
-3.80% | 203B | |
+8.36% | 171B | |
+0.19% | 163B |
- Stock Market
- Equities
- MRK Stock
- News Merck & Co., Inc.
- Transcript : Merck & Co., Inc. - Shareholder/Analyst Call